Narayana Hrudayalaya (NH) Q4 23/24 earnings summary

Executive summary

• Achieved record consolidated revenue of ₹50,182 million, up 10.9% year-over-year, with EBITDA of ₹12,275 million (24.5% margin) and PAT of ₹7,896 million (15.7% margin).

• Strong performance across flagship and new hospitals, with robust growth in India and Cayman operations.

• Continued investments in capacity expansion, digital transformation, and clinical excellence.

Financial highlights

• Consolidated revenue grew 10.9% year-over-year to ₹50,182 million; EBITDA margin at 24.5%.

• PAT increased to ₹7,896 million, up from ₹6,066 million last year.

• Standalone revenue rose to ₹32,657 million, with net profit at ₹4,245 million.

• Cayman business revenue reached USD 124 million, up 12.9% year-over-year.

• Net debt to equity ratio at 0.06; group cash and liquid investments at ₹12.58 billion.

Outlook and guidance

• Cardiac program expects substantial growth in procedural volume and revenue in FY25.

• Expansion plans include constructing over 1 million sq.ft. in the next 3-4 years.

• Continued focus on digital transformation, clinical excellence, and expansion in India and Caribbean markets.